A UK-based global biopharmaceutical company that researches, develops and markets prescription medicines and vaccines across areas including respiratory, HIV, oncology and immunology.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 55 | Added +9% | 548,661 | $26,429,000 | 0.1% |
| Ancora | 42 | Added +29% | 1,763 | $84,924 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Added +2080% | 87,213 | $4,201,050 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -100% | 8,400 | $404,628 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.